Katia Collomp | Health Sciences | Women Researcher Award

Posted on by Forensic Scientist

Prof. Dr. Katia Collomp | Health Sciences | Women Researcher Award

Professor, Orleans University | France

Professor Catherine (Katia) Collomp is a distinguished academic in Sport Sciences at the University of Orleans, France, and a Research Fellow at the French Antidoping Laboratory (LADF), University of Paris-Saclay. With an exceptional career dedicated to the intersection of pharmacology, exercise physiology, and anti-doping science, she is also a key member of the CIAMS laboratory. Her work has significantly influenced anti-doping policies and research ethics in sports science, making her a leading voice in the field.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Experience & Leadership
    Professor Collomp has over three decades of continuous and impactful contributions to sport sciences, pharmacology, and anti-doping research. Her role as a full professor and long-term research fellow at the French Antidoping Laboratory (LADF) demonstrates academic excellence and institutional commitment.

  • Interdisciplinary Expertise
    Her background as a pharmacist and researcher in physical activity and health sciences reflects a rare interdisciplinary blend that strengthens both the scientific rigor and practical impact of her work, especially in anti-doping studies—a field requiring deep knowledge of pharmacology, ethics, and sports physiology.

  • Global and National Collaborations
    Her postdoctoral research in Canada and continued collaborations with major institutions like University of Paris-Saclay and WADA position her as an internationally connected researcher. These connections indicate a high level of respect and trust in her expertise.

  • Institutional Service & Policy Impact
    Professor Collomp has held numerous leadership and advisory roles:

    • Co-director of the CIAMS lab team

    • Expert reviewer for HCERES

    • Member of ethics committees and national academic councils (CNU

🎓 Education

Katia Collomp began her academic journey by earning her degree in Pharmacy from the University of Montpellier I in 1987. She went on to complete her Ph.D. in 1991, focusing on “Physical activity, psychological and motor development” within the Life Sciences and Health section at the same university. 📘 Following her doctorate, she undertook a postdoctoral fellowship from 1992 to 1993 at the INRS Santé Antidoping Laboratory in Montréal, deepening her expertise in doping control and bioanalysis. She achieved her Habilitation à Diriger des Recherches (HDR) in 1997, establishing her as a senior scientific leader in her field.

💼 Experience

From 1993 to 1997, Katia served as a Pharmacist at the Mission Sports Medicine – Doping Control, Ministry of Sports in Paris, contributing to the foundation of anti-doping protocols. In 1997, she joined the French Antidoping Laboratory (LADF) as a Research Fellow, a position she continues to hold. Her academic path includes positions as Associate Professor (1997–2001) at the University of Paris XI and Full Professor (2001–present) at the University of Orleans. She has led multiple research teams and contributed to national committees on education and ethics.

🔬 Research Interest On Health Sciences

Her research interests span pharmacology, performance-enhancing substances, glucocorticoids, sports physiology, and rehabilitation. She focuses on the effects of physical activity on health and doping control, contributing to ethical frameworks and scientific methodologies that guide international sports policies. Her work helps shape understanding of how substances influence athletic performance and rehabilitation, playing a crucial role in global anti-doping efforts.

🏅 Awards & Honors

Professor Collomp has served in multiple national and international scientific committees, including as an expert for HCERES, a member of the WADA Glucocorticoids Threshold Working Group, and the Research Ethics Committee of Paris-Saclay (CER). She is currently a member of the French “Conseil National des Universités” (CNU 74), reflecting her respected status in the academic and sports science community. 🎖️ Her leadership and advocacy for scientific integrity in sports continue to influence generations of researchers and athletes alike.

📚 Publications

1. Hormonal and Metabolic Responses Across Phases of Combined Oral Contraceptive Use and Menstrual Cycle in Young Elite Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Caroline Teulier, Juliette Bonnigal, Nathalie Crépin, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, et al.

  • Year: 2025

  • Journal: European Journal of Applied Physiology

  • DOI: 10.1007/s00421-025-05745-x

2. Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes

  • Authors: Katia Collomp, Caroline Teulier, Carole Castanier, Juliette Bonnigal, Alexandre Marchand, Corinne Buisson, Magnus Ericsson, Nathalie Crépin, Emmanuelle Duron, Eric Favory, et al.

  • Year: 2025

  • Journal: Drug Testing and Analysis

  • DOI: 10.1002/dta.3859

3. Correlation Between Serum and Saliva Sex Hormones in Young Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Carole Castanier, Juliette Bonnigal, Valérie Bougault, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, et al.

  • Year: 2025

  • Journal: The Journal of Sports Medicine and Physical Fitness

  • DOI: 10.23736/s0022-4707.24.16488-2

4. Editorial: Women in Sports 2022

  • Authors: Katia Collomp, S. Lorenzetti

  • Year: 2024

  • Journal: Frontiers in Physiology

  • DOI: 10.3389/fphys.2024.1367605

5. Physical Activity and Female Students’ Perception of Menstrual Symptoms: Impact of Hormonal Contraception

  • Authors: Katia Collomp, Sandrine Schiano-Lomoriello, Carole Castanier, Corinne Buisson, Magnus Ericsson, Caroline Teulier, Valérie Bougault

  • Year: 2024

  • Conference Paper: HAL: hal-04936867

  • Citations: 0​

6. Correlation Between Serum and Saliva Sex Hormones in Young Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Carole Castanier, Caroline Teulier, Juliette Bonnigal, Valérie Bougault, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, et al.

  • Year: 2024

  • Conference Paper: HAL: hal-04936872

7. Physical Activity and Combined Hormonal Contraception: Association with Female Students’ Perception of Menstrual Symptoms

  • Authors: Valérie Bougault, Sandrine Schiano-Lomoriello, Carole Castanier, Corinne Buisson, Magnus Ericsson, Caroline Teulier, Katia Collomp

  • Year: 2023

  • Journal: Frontiers in Physiology

  • DOI: 10.3389/fphys.2023.1185343

8. Short-Term Effect of Bariatric Surgery on Cardiorespiratory Response at Submaximal, Ventilatory Threshold, and Maximal Exercise in Women with Severe Obesity

  • Authors: Nancy Vibarel-Rebot, Marine Asselin, Virgile Amiot, Katia Collomp

  • Year: 2023

  • Journal: Obesity Surgery

  • DOI: 10.1007/s11695-023-06550-1

9. Summer Olympic Sports and Female Athletes: Comparison of Anti-Doping Collections and Prohibited Substances Detected in Australia and New Zealand vs. France

  • Authors: Corinne Buisson, L. Brooker, C. Goebel, R. Morrow, R. Chakrabarty, N. Speers, A. Molina, Magnus Ericsson, Katia Collomp

  • Year: 2023

  • Journal: Frontiers in Sports and Active Living

  • DOI: 10.3389/fspor.2023.1213735

10. Prevalence of Prohibited Substance Use and Methods by Female Athletes: Evidence of Gender-Related Differences

  • Authors: Katia Collomp, Magnus Ericsson, N. Bernier, Corinne Buisson

  • Year: 2022

  • Journal: Frontiers in Sports and Active Living

  • DOI: 10.3389/fspor.2022.839976

🔚 Conclusion

Professor Catherine Collomp exemplifies the union of scientific excellence, ethical integrity, and academic leadership in the field of sport sciences and pharmacology. Her dedication to clean sport, athlete health, and rigorous scientific inquiry continues to guide anti-doping practices across the globe. Her nomination for any award would reflect her lifelong commitment to advancing science in service of both health and fairness in athletics.

Guowei Zheng | Medicine | Best Researcher Award

Posted on by Forensic Scientist

Prof. Dr. Guowei Zheng | Medicine | Best Researcher Award

Yunnan University of Chinese Medicine | China

Dr. Guowei Zheng is a distinguished professor at Yunnan University of Chinese Medicine, specializing in medicinal plant research. His work focuses on the collection, evaluation, and breeding of medicinal plant germplasm, as well as understanding plant responses to stress and exploring the biosynthetic pathways of medicinal ingredients in Chinese herbs. With extensive academic experience spanning over a decade, Dr. Zheng has made significant contributions to plant biology through multiomics approaches and phytochemical studies.

Profile👤

ORCID

Strengths for the Awards✨

  • Strong Research Output 📚

    • Dr. Zheng has published over 20 high-quality research papers in reputable journals, including BMC Plant Biology, Plant Diversity, PLoS ONE, and Phytochemistry.
    • His recent publications (2023–2025) demonstrate consistent research contributions, particularly in multi-omics, metabolomics, and medicinal plants.

  • Diverse Research Expertise 🔬

    • His work spans multiple critical areas, including medicinal plant breeding, stress response, and biosynthetic pathways of Chinese herbs.
    • His research on polyphyllin biosynthesis, glycerolipidome responses, and CO₂ elevation effects contributes to both fundamental science and applied plant biotechnology.

  • Academic and Professional Growth 📈

    • Rising from Assistant Professor (2010) to Full Professor (2021) at Yunnan University of Chinese Medicine.
    • Previous tenure at Kunming Institute of Botany, Chinese Academy of Sciences, a prestigious research institution.

🎓 Education

  • Ph.D. in Botany (2005–2010) – Kunming Institute of Botany, Chinese Academy of Sciences
  • Bachelor’s Degree in Biology (2001–2005) – Yunnan University

👨‍🏫 Experience

  • Professor (2021–Present) – Yunnan University of Chinese Medicine
  • Associate Professor (2018–2021) – Yunnan University of Chinese Medicine
  • Associate Professor (2016–2018) – Kunming Institute of Botany, Chinese Academy of Sciences
  • Assistant Professor (2010–2015) – Kunming Institute of Botany, Chinese Academy of Sciences

🔬 Research Interests On Medicine

  • 🌿 Medicinal Plant Germplasm – Collection, evaluation, and breeding of medicinal plant species
  • 💧 Plant Stress Response – Studying how medicinal plants adapt to environmental stressors
  • 🧪 Phytochemical Biosynthesis – Investigating synthesis pathways of medicinal compounds in Chinese herbs

🏆 Awards

(Please provide specific awards or recognitions received.)

📚 Publications

Dr. Zheng has published extensively in high-impact journals, contributing significantly to plant biology and phytochemistry.

  • Xu, P., Mi, Q., Zhang, X., Zhang, X., Yu, M., Gao, Y., Wan, X., Chen, Y., Li, Q., Chen, J., & Zheng, G. (2025). Dissection of transcriptome and metabolome insights into the polyphyllin biosynthesis in Paris. BMC Plant Biology, 25(1), 206.

  • Xu, P., Chen, J., Mi, Q., Li, W., Lu, Y., Luo, W., Yu, M., Zhang, X., Tu, Z., Xu, H., & Zheng, G. (2024). Metabolomics and transcriptomics profiling of three Paris species with varied polyphyllin compositions. Sci Data, 11(1), 1293.

  • Zheng, G., Li, W., Zhang, S., Mi, Q., Luo, W., Zhao, Y., Qin, X., Li, W., Pu, S., & Xu, F. (2023). Multiomics strategies for decoding seed dormancy breakdown in Paris polyphylla. BMC Plant Biology, 23(1), 247.

  • Li, W., Zhang, X., Pei, W., & Zheng, G. (2021). First Report of Root Rot Caused by Dactylonectria torresensis on Bletilla striata (Baiji) in Yunnan, China. Plant Disease, 0(0), PDIS-10-20-2166-PDN.

  • Liu, T., Chen, J., Xu, F., He, X., Yang, S., Zhu, Y., Li, W., & Zheng, G. (2020). Analysis of changes in the Panax notoginseng glycerolipidome in response to long-term chilling and heat. Plant Diversity, 42, 102-110.

  • Zheng, G., Cheng, J., & Li, W. (2020). Impacts of CO2 elevation on the physiology and seed quality of soybean. Plant Diversity, 42(1), 44-51.

  • Zheng, G., Luo, S., Li, S., Hua, J., Li, W., & Li, S. (2018). Specialized metabolites from Ageratina adenophora and their inhibitory activities against pathogenic fungi. Phytochemistry, 148, 57-62.

  • Zheng, G., & Li, W. (2017). Profiling membrane glycerolipids during gamma-ray-induced membrane injury. BMC Plant Biology, 17(1), 203.

  • Chen, J., Zheng, G., Zhang, Y., Aisa, H. A., & Hao, X. (2017). Phytotoxic Terpenoids from Ligularia cymbulifera Roots. Front Plant Sci, 7, 2033.

  • Zheng, G., Li, L., & Li, W. (2016). Glycerolipidome responses to freezing- and chilling-induced injuries: examples in Arabidopsis and rice. BMC Plant Biology, 16, 70.

  • Tang, T., Liu, P., Zheng, G., & Li, W. (2016). Two phases of response to long-term moderate heat: Variation in thermotolerance between Arabidopsis thaliana and its relative Arabis paniculata. Phytochemistry, 122, 81-90.

🔚 Conclusion

Dr. Guowei Zheng is a leading researcher in medicinal plant biology, with expertise in plant stress adaptation and bioactive compound biosynthesis. His contributions to plant sciences and phytochemistry continue to advance our understanding of medicinal herbs, making a significant impact on the field of traditional Chinese medicine and agricultural biotechnology.

Guoli Li | Medicine | Best Researcher Award

Posted on by Forensic Scientist

Dr. Guoli Li | Medicine | Best Researcher Award

Researcher | Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University) | China

Dr. Guoli Li, Ph.D., is an Assistant Professor at Hunan Provincial People’s Hospital and the First Affiliated Hospital of Hunan Normal University, located in Changsha, China. With expertise in Molecular Medicine, Cancer Research, and Nephrology, Dr. Li has contributed extensively to the scientific community, focusing on cutting-edge advancements in medical research.

Profile

Google Scholar

Strengths for the Awards

  • Extensive Research Background:
    Dr. Guoli Li has a strong academic and research foundation in molecular medicine, cancer research, and nephrology, with significant experience at reputable institutions like the University of Texas MD Anderson Cancer Center and Hunan Normal University.
  • Diverse Publication Record:
    Dr. Li has authored numerous high-impact publications in peer-reviewed journals such as Frontiers in Oncology, Genes and Diseases, and BMC Nephrology. These papers cover critical topics like cancer biomarkers, glomerulopathy, and ferroptosis in cancer, demonstrating expertise in innovative and clinically relevant research.
  • Bibliometric Contributions:
    Contributions to bibliometric studies (e.g., research on ferroptosis and mitophagy) highlight Dr. Li’s ability to analyze global research trends, adding to their scholarly influence.

Education 🎓

  • Ph.D. in Biochemistry and Molecular Biology (2013–2017)
    Central South University, Changsha, Hunan, China
  • B.S. in Biotechnology (2008–2012)
    Changchun University of Technology, Changchun, Jilin, China

Experience 💼

  • Research Scientist (09/2020–Present)
    Hunan Provincial People’s Hospital, Hunan Normal University, Changsha, Hunan, China
  • Postdoctoral Fellow (09/2018–08/2020)
    The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
  • Instructor (06/2018–06/2020)
    Guangzhou Medical University, Guangzhou, Guangdong, China
  • Technician (08/2012–08/2013)
    Sansure Biotech Inc., Changsha, Hunan, China

Research Interests On Molecular Medicine🔬

Dr. Li’s research spans:

  • Molecular mechanisms in cancer biology 🧬
  • Nephrology, focusing on lupus nephritis and glomerulopathy 🩺
  • Biomarker identification and therapeutic development 🚑

Awards 🏆

  • 2018: Outstanding Graduate
  • 2016-2017: Excellent Graduate Student
  • 2009-2010: Excellent Student and Excellent Student Leader

Publications 📚

  • Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing
    Authors: G Li, X Guo, L Tang, M Chen, X Luo, L Peng, X Xu, S Wang, Z Xiao, W Yi, …
    Year: 2017
    Citations: 43
  • Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
    Authors: G Li, X Guo, M Chen, L Tang, H Jiang, JX Day, Y Xie, L Peng, X Xu, J Li, …
    Year: 2018
    Citations: 39
  • What’s the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients
    Authors: W Wang, H Liu, G Li
    Year: 2022
    Citations: 26
  • Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients
    Authors: J Heng, X Guo, W Wu, Y Wang, G Li, M Chen, L Peng, S Wang, L Dai, …
    Year: 2017
    Citations: 20
  • The research landscape of ferroptosis in cancer: a bibliometric analysis
    Authors: G Li, Y Liang, H Yang, W Zhang, T Xie
    Year: 2022
    Citations: 17
  • Mutation screening of 10 cancer susceptibility genes in unselected breast cancer patients
    Authors: Y Xie, G Li, M Chen, X Guo, L Tang, X Luo, S Wang, W Yi, L Dai, J Wang
    Year: 2018
    Citations: 16
  • Hyperuricemia is an independent risk factor for renal pathological damage and poor prognosis in lupus nephritis patients
    Authors: T Xie, M Chen, X Tang, H Yin, X Wang, G Li, J Li, X Zuo, W Zhang
    Year: 2016
    Citations: 16
  • Comprehensive analysis of serum tumor markers and BRCA1/2 germline mutations in Chinese ovarian cancer patients
    Authors: H Deng, M Chen, X Guo, J Heng, X Xu, L Peng, H Jiang, G Li, JX Day, J Li, …
    Year: 2019
    Citations: 11
  • Bibliometric insights of global research landscape in mitophagy
    Authors: G Li, W Yin, Y Yang, H Yang, Y Chen, Y Liang, W Zhang, T Xie
    Year: 2022
    Citations: 10
  • LINC00467 is upregulated by DNA copy number amplification and hypomethylation and shows ceRNA potential in lung adenocarcinoma
    Authors: W Wang, H Bo, Y Liang, G Li
    Year: 2022
    Citations: 9

Conclusion 📝

Dr. Guoli Li is a passionate scientist and educator committed to advancing medical research and improving clinical outcomes. With numerous prestigious publications, awards, and invitations as a reviewer for reputed journals, Dr. Li continues to contribute profoundly to the global research community. 🌐